Teriparatide vs. Abaloparatide: Comparing the Two FDA-Approved Bone-Building Peptides
If your doctor has raised the subject of bone-building injections for osteoporosis, you have likely encountered two names: teriparatide (Forteo) and abaloparatide (Tymlos). Both require a daily subcutaneous shot, both are capped at 24 months of lifetime use, and both target the parathyroid hormone receptor. So which one is better — and does the difference […]
Teriparatide vs. Abaloparatide: Comparing the Two FDA-Approved Bone-Building Peptides Read More »









